Clinical Trial Update: Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of clobetasol topical oil for children with moderate to severe atopic dermatitis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Clobetasol topical oil (clobetasol)

Snippet

Sponsor: Hill Dermaceuticals, Inc. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-23